CELLINK and Carcinotech partner to transform cancer drug development with 3D bioprinting
Carcinotech and 3D bioprinting firm CELLINK have announced a partnership to accelerate cancer drug development with 3D bioprinted tumor models.
LATEST NEWS
- 02 / 04 : Nivalon Leverages AI and 3D Printing to Create Personalized, Motion-Preserving Spinal Implants
- 02 / 03 : Building a Tiny Kingdom: 3D Printing the Perfect Hamster Habitat
- 01 / 31 : 3D Printed Metal Prostheses Offer New Hope for Distal Radius Giant Cell Tumor Patients
- 01 / 24 : Create it REAL and Vitalitecs bring digital orthopedic manufacturing to Mexico
- 01 / 23 : Obayashi Corporation advances WAAM for architectural possibilities Additive Manufacturing
2026-02-05